Search for: "Bristol Myers Squibb" Results 361 - 380 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jan 2020, 9:25 am by Beth Mole
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week. [read post]
12 Mar 2008, 9:17 am
Safeway's adoption of my poison pill by-law was preceded by an adoption last month by CVS Caremark, an adoption by Disney, and an adoption by Bristol-Myers Squibb. [read post]
7 Apr 2010, 1:36 pm by Amir Efrati
The Third Circuit Court of Appeals today rejected the Justice Department’s attempt to reinstate part of its prosecution of Frederick Schiff, former chief financial officer at Bristol-Myers Squibb, the large pharmaceuticals company. [read post]
3 Apr 2008, 9:50 am
Safeway, CVS Caremark, and Bristol-Myers Squibb, like JCPenney now, amended their by-laws following an agreement with me that made a shareholder vote unnecessary. [read post]
26 Jan 2012, 10:20 am by info@thomasjhenrylaw.com
Bristol-Myers Squibb Co., the manufacturer of these, issued a warning to physicians in June 2011 stating that using steroids as epidurals may cause a stroke if the drug is accidentally shot into an artery. [read post]
12 Apr 2017, 2:22 pm by Tom Lamb
An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin   (Posted by Tom Lamb at DrugInjuryWatch.com)   In the US, there are currently four direct-acting oral anticoagulants (DOACs), a relatively new class of blood thinners, approved for the prevention of stroke in patients with atrial fibrillation (AF): Pradaxa (dabigatran) -- approved by FDA in 2010 -- Boehringer Ingelheim Pharmaceuticals Xarelto… [read post]
22 Mar 2013, 2:52 pm
Byetta, made by Bristol-Myers Squibb and Januvia, manufactured by Merck are two such diabetes drugs that have caused concern. [read post]
25 Mar 2013, 2:38 pm
Food and Drug Administration, it was reviewing unpublished data by medical researchers which suggest that pre-cancerous cellular changes may be associated with Type 2 diabetes drugs known as incretin mimetics, including Bristol-Myers Squibb’s Byetta and Novo Nordisk’s Victoza. [read post]
3 Jul 2013, 3:12 pm
There have been an increasing number of lawsuits filed against the manufacturers of these drugs, Merck and Bristol-Myers Squibbs. [read post]
10 Jun 2013, 11:23 am
Thakur began his work at Ranbaxy in early 2004 after he was recruited from the brand-name pharmaceutical company Bristol-Myers Squibb (BMY) based out of New Jersey. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
In so holding, the court determined that the Supreme Court’s ruling in a mass tort action, Bristol-Myers Squibb Co. v. [read post]
13 Oct 2009, 9:59 pm
As part of the effort to encourage these companies to pool their patents, MSF has launched an e-mail writing campaign calling on Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline, Merck & Co, Pfizer, and Sequoia Pharmaceuticals to place specific HIV drug patents... [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
8 Oct 2020, 9:45 am by Patrick A. Malone
The prescription medications targeted by the lawmakers included “Celgene and Bristol Myers Squibb’s Revlimid cancer treatment, which saw its price hiked 23 times since 2005, and Teva’s multiple sclerosis drug Copaxone, which went up in price 27 times since 2007,” reported the independent, nonpartisan Kaiser Health News service. [read post]